Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 23:10:24 UTC, with 13 holding rows worth $2,783,915.

Accession
0000919574-26-007854
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 13 entries on the cover page, a total value of $2,783,915 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,783,915 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPACE EXPLORATION TECHN CORP CLASS A COM STK84615Q103Stock3,699$557,959dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
New Fortress Energy Inc.643926207Convertible Preferred Stock1,214$485,612dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
Berkshire Hathaway Inc084670702COM839$417,659dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
Tesla Motors, Inc88160R101COM829$294,263dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
Vanguard S&P 500 ETF922908363COM378$264,716dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
Alphabet Inc. Reg. Shares A02079K305COM769$264,562dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BLACKSTONE INC09260D107COM1,780$199,534dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
KYVERNA THERAPEUTICS INC501976104COMMON STOCK12,347$83,958dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
LEXEO THERAPEUTICS INC52886X107COMMON STOCK16,962$57,333dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK27,775$57,078dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
X4 PHARMACEUTICALS INC98420X202COMMON STOCK13,534$39,248dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SAB BIOTHERAPEUTICS INC78397T202COMMON STOCK10,372$32,878dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK20,946$29,115dollars as filedThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-26-007854this filing2026-11-16